MIA News Archives

Study reveals schizophrenia patients find little support from mental health staff in reducing side effects-heavy drugs.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

A new study by Peter Groot and Jim van Os investigated whether tapering strips can help people stop using antidepressants.

Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.

New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

New research examines service user attitudes on discontinuing and reducing antipsychotic drugs.

Over 70% of schizophrenia patients who are "treatment resistant" have apparently developed dopamine supersensitivity psychosis from long-term use of antipsychotic medications.

Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

Benzodiazepine medications that are commonly used for calming or sedating people can sometimes apparently cause violent or aggressive responses in some people, according to...

A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.

Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.

Common scientific beliefs about serotonin levels in depression and how antidepressants act on the brain appear to be completely backwards.

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

Ever higher levels of pharmaceutical drugs are turning up in drinking water supplies, and an op-ed in the UK Mirror discusses a study that...

“Live, healthy babies are the most common outcome following the use of antipsychotic medication in pregnancy,” conclude Australian researchers in a study that was...

Researchers from the Cochrane Center and University of Copenhagen in Denmark, publishing in the May issue of Addiction, "explore the rationale for claiming that...

A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.

Zoloft caused up to six-fold increases in build-up of atherosclerosis plaque in the coronary arteries of monkeys.

Qualitative study finds that both internal resources and systemic factors play a role in antipsychotic discontinuation outcomes.

Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.

People who take SSRI antidepressants are twice as likely to have their dental implants fail, according to McGill University researchers. In a press release,...